First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference15 articles.
1. Corrigendum: pazopanib in metastatic renal cancer: a "Real-World" experience at National Cancer Institute "Fondazione G. Pascale";Cecerev;Front. Pharmacol.,2016
2. Pazopanib in the treatment of advanced renal cell carcinoma;Cella;Ther. Adv. Urol.,2016
3. Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial;Guo;J. Hematol. Oncol.,2018
4. Successful re-administration of pazopanib in a patient with metastatic renal cell carcinoma and a history of pazopanib-induced nephrotic syndrome: a case report;Jeon;BMC Nephrol.,2019
5. Initial experience with first-line pazopanib in the treatment of metastatic renal cell carcinoma: a single institution data;Joshi;Indian J. Cancer,2016
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck;Frontiers in Oncology;2023-12-13
2. Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis;Frontiers in Pharmacology;2023-09-07
3. Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy;The Chemical Record;2022-09-14
4. Renal cell carcinoma with early skin metastasis and partial response on tyrosine kinase inhibitor: A case report;International Journal of Surgery Case Reports;2022-05
5. Recent Trends in rationally designed molecules as kinase inhibitors;Current Medicinal Chemistry;2021-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3